Becker's Healthcare August 22, 2024
The FDA signed off on updated mRNA COVID-19 vaccines from Pfizer and Moderna. The new shots target the KP.2 strain and are expected to be available at pharmacies, hospitals and clinics within a few days, the drugmakers said.
The updated shots were approved for those 12 and older and received emergency use authorization for children ages 6 months through 11 years.
“Given waning immunity of the population from previous exposure to the virus and from prior vaccination, we strongly encourage those who are eligible to consider receiving an updated COVID-19 vaccine to provide better protection against currently circulating variants,” Peter Marks, MD, PhD, director of the FDA’s Center for Biologics Evaluation and Research, said in an Aug. 22 news...
Today's Sponsors
Today's Sponsor